JAK2-IN-4 (compound 16h) is a selective inhibitor of JAK2 and JAK3, with IC50 values of 0.7 nM and 23.2 nM, respectively; it is used as a research tool for studying JAK-STAT signaling pathways and has potential therapeutic applications in diseases involving dysregulated JAK2/JAK3 activity, such as myeloproliferative disorders and autoimmune conditions.